# Squamous Cell Carcinoma of studies recruiting: 51 (2026)

ClinicalTrials.gov lists 51 trials that are observational for Squamous Cell Carcinoma of Head and Neck that are recruiting or not yet recruiting.

## The full list

Recruiting observational Squamous Cell Carcinoma of Head and Neck studies: 51 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/squamous-cell-carcinoma-of-head-and-neck

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 51
- Recruiting or not yet: 51
- Read on: November 19, 2026

## Trials

The 25 newest of 51, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07915570 | Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers | British University In Egypt | Observational | Recruiting | Oral Potentially Malignant Disorders, Oral Lichen Planus, Oral Leukoplakia, Oral Squamous Cell Carcinoma, Smoking | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915570) |
| August 31, 2026 | NCT07794813 | Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer | Yunnan Cancer Hospital | Observational | Recruiting | Oral Squamous Cell Carcinoma (OSCC), Diagnosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794813) |
| August 4, 2026 | NCT07745803 | Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Observational | Not yet recruiting | Oral Squamous Cell Carcinoma (OSCC), Periodontal Disease, Dental Caries | 4,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745803) |
| July 9, 2026 | NCT07692360 | Salivary IL-6 and Interleukin Gene Polymorphisms in Oral Squamous Cell Carcinoma | University of Pavia | Observational | Not yet recruiting | Oral Squamous Cell Carcinoma (OSCC) | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692360) |
| April 14, 2026 | NCT07529769 | Artificial Intelligence for the Diagnosis of Oral Lesions | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Oral Potentially Malignant Disorders, Oral Cavity Squamous Cell Carcinoma | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07529769) |
| April 6, 2026 | NCT07512921 | Matching Primary Tumor and Blood Gene Expression Analysis of HPV-negative Squamous Head and Neck Cancers | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Observational | Recruiting | Head and Neck (HNSCC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07512921) |
| April 6, 2026 | NCT07511413 | GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients | Fondazione del Piemonte per l'Oncologia | Observational | Recruiting | Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer, Lung Cancer | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511413) |
| March 13, 2026 | NCT07471009 | Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kinase Receptor Expression in Patients With Squamous Cell Head... | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Not yet recruiting | Squamous Cell Tumors of the Head and Neck (HNSCC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07471009) |
| March 4, 2026 | NCT07448727 | Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell... | University of Rome Tor Vergata | Observational | Recruiting | Head & Neck Cancer, Head & Neck Squamous Cell Carcinoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448727) |
| February 18, 2026 | NCT07417605 | Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in... | University Hospital, Brest | Observational | Recruiting | Head & Neck Squamous Cell Carcinoma | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07417605) |
| January 15, 2026 | NCT07343271 | Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx | University Hospital, Strasbourg, France | Observational | Recruiting | Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07343271) |
| November 24, 2025 | NCT07246759 | Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis | OncoHost Ltd. | Observational | Not yet recruiting | Non Small Cell Lung Cancer (NSCLC), Melanoma (Skin Cancer), Triple Negative Breast Cancer (TNBC), RCC, Renal Cell... | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246759) |
| August 21, 2025 | NCT07133958 | A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC | Zhujiang Hospital | Observational | Recruiting | Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07133958) |
| August 20, 2025 | NCT07131566 | Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07131566) |
| August 17, 2025 | NCT07127614 | Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma | Al-Azhar University | Observational | Not yet recruiting | Squamous Cell Carcinoma Mouth | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07127614) |
| April 27, 2025 | NCT06947668 | Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel | University of Erlangen-Nürnberg Medical School | Observational | Recruiting | Squamous Cell Carcinoma of Oropharynx, Squamous Cell Carcinoma of the Hypopharynx, Larynx Squamous Cell Carcinoma, Oral... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06947668) |
| April 16, 2025 | NCT06929468 | Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Ototoxic Hearing Loss, Ototoxicity, Drug-Induced, Cisplatin-induced Hearing Loss, Cisplatin Ototoxicity, Head and Neck... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06929468) |
| April 1, 2025 | NCT06905145 | Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis | National Cancer Institute, Naples | Observational | Recruiting | Head and Neck Squamous Cell Carcinoma, Locally Advanced Stage | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06905145) |
| February 11, 2025 | NCT06821243 | Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention | Regina Elena Cancer Institute | Observational | Recruiting | Squamous Cell Carcinoma of Oropharynx | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06821243) |
| January 1, 2025 | NCT06755762 | Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer | Chang Gung Memorial Hospital | Observational | Recruiting | Circulating Tumor Cell, HNSCC | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06755762) |
| December 20, 2024 | NCT06744296 | Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous... | Massachusetts Eye and Ear Infirmary | Observational | Recruiting | Squamous Cell Carcinoma of Head and Neck | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06744296) |
| December 10, 2024 | NCT06727162 | The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Recruiting | Head and Neck Squamous Cell Carcinoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06727162) |
| November 13, 2024 | NCT06686342 | PDO Based Drug Sensitive Test in R/M HNSCC | Huashan Hospital | Observational | Recruiting | Head and Neck Squamous Cell Carcinoma, Patient Derived Organoid, Drug Sensitive Test in Vitro | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06686342) |
| November 7, 2024 | NCT06678724 | Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell... | National Taiwan University Hospital | Observational | Recruiting | Head and Neck Cancers- Squamous Cell, Head and Neck Cancer Metastatic, Recurrent Head and Neck Squamous Cell Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06678724) |
| September 20, 2024 | NCT06606028 | Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma | University of California, San Francisco | Observational | Recruiting | Squamous Cell Carcinoma of Head and Neck, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Squamous Cell Carcinoma... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06606028) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Erlangen-Nürnberg Medical School | 3 |
| National Cancer Institute, Naples | 2 |
| [Viome](https://specstream.ai/data/clinical-trials/company/viome) | 2 |
| Regina Elena Cancer Institute | 2 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| British University In Egypt | 1 |
| National Health Research Institutes, Taiwan | 1 |
| Region Skane | 1 |
| AIO-Studien-gGmbH | 1 |
| OncoHost Ltd. | 1 |
| Vanderbilt University Medical Center | 1 |
| Chang Gung Memorial Hospital | 1 |
| University Hospital Freiburg | 1 |
| University of Pavia | 1 |
| Fondazione del Piemonte per l'Oncologia | 1 |
| University Hospital, Brest | 1 |
| Yunnan Cancer Hospital | 1 |
| Aalborg University Hospital | 1 |
| Proteocyte Diagnostics Inc. | 1 |
| Huashan Hospital | 1 |
| Tempus AI | 1 |
| Al-Azhar University | 1 |

## By country

| Country | Trials |
| --- | --- |
| Italy | 13 |
| United States | 10 |
| Germany | 9 |
| China | 6 |
| France | 4 |
| Taiwan | 3 |
| Belgium | 3 |
| Egypt | 2 |
| Sweden | 2 |
| Spain | 2 |
| Cyprus | 1 |
| Czechia | 1 |
| Switzerland | 1 |
| Denmark | 1 |
| Canada | 1 |
| Puerto Rico | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Real estate law firms in the United States](https://specstream.ai/data/businesses/real-estate-law-firms/united-states)
- [Screen printers in the United States](https://specstream.ai/data/businesses/screen-printers/united-states)
- [Specialized medical facilities in the United States](https://specstream.ai/data/businesses/specialized-medical-facilities/united-states)
- [Taiwanese restaurants in the United States](https://specstream.ai/data/businesses/taiwanese-restaurants/united-states)
- [Trailer repair shops in the United States](https://specstream.ai/data/businesses/trailer-repair-shops/united-states)
- [Venezuelan restaurants in the United States](https://specstream.ai/data/businesses/venezuelan-restaurants/united-states)
